⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Vivimed Labs Limited and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Vivimed Labs Limited
↗Hyderabad, India
Vivimed Labs is an India-based global supplier of specialty chemicals and pharmaceuticals, headquartered in Hyderabad. The company operates through two primary segments: Specialty Chemicals (supplying active ingredients for home, personal care, and industrial applications) and Pharma Business (manufacturing APIs, intermediates, and finished dosage formulations).
Founded in 1988, the company has expanded its global footprint through acquisitions, including UQUIFA and SONEAS, allowing it to serve regulated markets. Its pharmaceutical division focuses on therapeutic areas such as oncology, tuberculosis, diabetes, and pain management, utilizing a business model that emphasizes contract research, manufacturing (CDMO), and product licensing.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Revenue:$10M-$20M
Founded:1988
Ownership:public
Status:operating
STOCK
Exchange:National Stock Exchange of India
Ticker:VIVIMEDLAB
Market Cap:$0.006B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, API
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Vivimed Labs USA Inc, Vivimed Labs Europe Ltd, UQUIFA, SONEAS
Key Partnerships:Global pharmaceutical players (e.g., GSK, Pfizer, Gilead, Esteve) for CDMO services
COMPETITION
Position:Niche Player
Competitors:RA Chem Pharma
LEADERSHIP
Key Executives:
Santosh Varalwar - Managing Director & CEO
Dr. V. Manohar Rao - Chairman
LINKS
Website:vivimedlabs.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Vivimed Labs Limited. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.